Immunome (IMNM)
(Delayed Data from NSDQ)
$14.34 USD
+0.08 (0.56%)
Updated Sep 26, 2024 03:59 PM ET
After-Market: $14.35 +0.01 (0.07%) 7:20 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/14/2024
Time: -- |
9/2024 | $-0.60 | 0.00% |
Earnings Summary
For their last quarter, Immunome (IMNM) reported earnings of -$0.49 per share, missing the Zacks Consensus Estimate of -$0.38 per share. This reflects a negative earnings surprise of 28.95%. Look out for IMNM's next earnings release expected on November 14, 2024. For the next earning release, we expect the company to report earnings of -$0.60 per share, reflecting a year-over-year decrease of 66.67%.
Earnings History
Price & Consensus
Zacks News for IMNM
Cartesian Therapeutics, Inc. (RNAC) Q2 Earnings and Revenues Top Estimates
IMNM: What are Zacks experts saying now?
Zacks Private Portfolio Services